Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
AARN News Letter
|
March 1, 1993
Helpful information for members considering employment outside Alberta
C L Dekker
Current Clinical Topics in Infectious Diseases
|
September 27, 2001
Antiviral agents effective against herpesviruses
C L Dekker, C G Prober
The Pediatric Infectious Disease Journal
|
December 6, 2001
Pediatric uses of valacyclovir, penciclovir and famciclovir
C L Dekker, C G Prober
ANNA Journal
|
April 1, 1993
Research series: Part 2 of 6. Annotated bibliography: research proposal development and literature review
P S Jordan, C Berry, C L Dekker, et al.
Annals of Internal Medicine
|
June 15, 1995
A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]
A G Langenberg, R L Burke, S F Adair, et al.
ANNA Journal
|
October 1, 1993
Annotated bibliography: general research texts and statistics
C L Dekker, P S Jordan, N J Birkett, et al.
The Journal of Infectious Diseases
|
November 1, 1994
Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers
J O Kahn, F Sinangil, J Baenziger, et al.
American Journal of Diseases of Children (1960)
|
August 1, 1990
Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children
E A Mortimer, M Kimura, J D Cherry, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1990
Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children
C M Morgan, D A Blumberg, J D Cherry, et al.
The Journal of Pediatrics
|
July 1, 1990
Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody
D A Blumberg, C M Mink, J D Cherry, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
AARN News Letter
|
March 1, 1993
Helpful information for members considering employment outside Alberta
C L Dekker
Current Clinical Topics in Infectious Diseases
|
September 27, 2001
Antiviral agents effective against herpesviruses
C L Dekker, C G Prober
The Pediatric Infectious Disease Journal
|
December 6, 2001
Pediatric uses of valacyclovir, penciclovir and famciclovir
C L Dekker, C G Prober
ANNA Journal
|
April 1, 1993
Research series: Part 2 of 6. Annotated bibliography: research proposal development and literature review
P S Jordan, C Berry, C L Dekker, et al.
Annals of Internal Medicine
|
June 15, 1995
A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]
A G Langenberg, R L Burke, S F Adair, et al.
ANNA Journal
|
October 1, 1993
Annotated bibliography: general research texts and statistics
C L Dekker, P S Jordan, N J Birkett, et al.
The Journal of Infectious Diseases
|
November 1, 1994
Clinical and immunologic responses to human immunodeficiency virus (HIV) type 1SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidylethanolamine in non-HIV-infected human volunteers
J O Kahn, F Sinangil, J Baenziger, et al.
American Journal of Diseases of Children (1960)
|
August 1, 1990
Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children
E A Mortimer, M Kimura, J D Cherry, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1990
Comparison of acellular and whole-cell pertussis-component DTP vaccines. A multicenter double-blind study in 4- to 6-year-old children
C M Morgan, D A Blumberg, J D Cherry, et al.
The Journal of Pediatrics
|
July 1, 1990
Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody
D A Blumberg, C M Mink, J D Cherry, et al.
Page
of 2